NasdaqGS:CMPSBiotechs
Has The Surge In COMPASS Pathways (CMPS) Shares Left The Valuation Looking Stretched?
Wondering whether COMPASS Pathways at around US$9.15 still stacks up on value or has run ahead of itself? This article breaks down what the recent moves might mean for you as an investor.
The stock has recently shown strong momentum, with returns of 37.4% over 7 days, 75.3% over 30 days, 39.7% year to date and 129.3% over 1 year, while the 3 year return sits at 13.2% and the 5 year return at a loss of 76.5%.
These swings have come as COMPASS Pathways continues to sit in the spotlight of...